ERN1 and Parkinson disease: Taken together, these data highlight that XBP1 expression downstream of IRE1α is neuroprotective and may represent a possible therapeutic target but that other XBP1-independent IRE1α signaling pathways have the potential to act in a deleterious fashion in PD.